Financial & competing interests disclosure
C Verslype has received research funding and consultancy honoraria from Bayer, Ipsen and Novartis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict withthe subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.